Title: Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric
endoscopic submucosal dissection-induced ulcer: An updated systematic review and meta-
analysis
Version: 1 Date: 16 Jan 2024
Reviewer's report:
This article adopts a randomized controlled method, involving a total of 926 patients, to compare
the incidence of complications after gastric mucosal dissection using  vonoprazan and PPI.
Compared with PPI,  vonoprazan has advantages in delayed bleeding, reasonable experimental
design, reliable data, and can be published.
Title: Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric
endoscopic submucosal dissection-induced ulcer: An updated systematic review and meta-
analysis
Version: 1 Date: 16 Jan 2024
Reviewer's report:
This article adopts a randomized controlled method, involving a total of 926 patients, to compare
the incidence of complications after gastric mucosal dissection using  vonoprazan and PPI.
Compared with PPI,  vonoprazan has advantages in delayed bleeding, reasonable experimental
design, reliable data, and can be published.
Please review this paper.
user
Title: Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric
endoscopic submucosal dissection-induced ulcer: An updated systematic review and meta-
analysis
Version: 1 Date: 16 Jan 2024
Reviewer's report:
This article adopts a randomized controlled method, involving a total of 926 patients, to compare
the incidence of complications after gastric mucosal dissection using  vonoprazan and PPI.
Compared with PPI,  vonoprazan has advantages in delayed bleeding, reasonable experimental
design, reliable data, and can be published.
assistant